InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Autor Deborah M., Chief Policy Officer. Director active across 2 companies, notably Hims & Hers Health, Inc.. Aggregated, 16 disclosures have been recorded. Split: 0 buy · 5 sells. Total volume traded: €1.2m. History available since 16 May 2024. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Autor Deborah M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
16,773 shares@ US$27.85Class A Common StockSEC:0001884671-26-000004:0
32,920 sharesClass A Common StockSEC:0001773751-26-000209:0
16,147 shares@ US$28.150.0071% mcap64.1% of flowClass A Common StockSEC:0001773751-26-000209:1
32,919 sharesClass A Common StockSEC:0001773751-26-000130:0
15,396 sharesClass A Common StockSEC:0001773751-26-000130:1
3,656 sharesClass A Common StockSEC:0001773751-26-000112:0
34,819 shares@ US$12.940.0070% mcap72.6% of flowClass A Common StockSEC:0001628280-26-034106:0
32,919 sharesClass A Common StockSEC:0001884671-26-000002:0
7,054 shares@ US$36.710.0040% mcap50.0% of flowClass A Common StockSEC:0001884671-25-000005:0
7,054 sharesClass A Common StockSEC:0001773751-25-000382:0
6,175 sharesClass A Common StockSEC:0001773751-25-000205:0
40,258 sharesClass A Common StockSEC:0001628280-25-023998:0
6,771 shares@ US$8.4110.2% of flowClass A Common StockSEC:0001628280-24-049149:0
14,553 shares@ US$6.7617.2% of flowClass A Common StockSEC:0001628280-24-024342:0
76,453 sharesClass A Common StockSEC:0001628280-24-023258:0
54,949 sharesClass A Common StockSEC:0001209191-23-043988:0
16 of 16 declarations
About Autor Deborah M.
Autor Deborah M. is Chief Policy Officer at Hims & Hers Health, Inc. and a director at Amneal Pharmaceuticals, Inc. The record shows 13 filings in total, and across the 13 sampled filings from 2023-08-01 to 2026-06-17, they show EUR 747391 of sales and EUR 0 of purchases, with Levée d'options as the most common transaction type.
